Abstract
Zn-based biodegradable metals (BMs) are regarded as revolutionary biomaterials for bone implants. However, their clinical application is limited by insufficient mechanical properties, delayed in vivo degradation, and overdose-induced Zn2+ toxicity. Herein, innovative multi-material additive manufacturing (MMAM) is deployed to construct a Zn/titanium (Ti) hetero-structured composite. The biodegradation and biofunction of Zn exhibited intriguing characteristics in composites. A potential difference of about 300 mV naturally existed between Zn and Ti. This natural potential difference triggered galvanic coupling corrosion, resulting in 2.7 times accelerated degradation of Zn. The excess release of Zn2+ induced by accelerated degradation enhanced the antibacterial function. A voltage signal generated by the natural potential difference also promoted in vitro osteogenic differentiation through activating the PI3K-Akt signaling pathway, and inhibited the toxicity of overdose Zn2+ in vivo, significantly improving bone regeneration. Furthermore, MMAM technology allows for the specific region deployment of components. In the future, Ti and Zn could be respectively deployed in the primary and non-load-bearing regions of bone implants by structural designs, thereby achieving a functionally graded application to overcome the insufficient mechanical properties of Zn-based BMs. This work clarifies the functional optimization mechanism for multimetal bone implants, which possibly breaks the application dilemma of Zn-based BMs.